Systemic hypertension versus intraglomerular hypertension in progression
نویسندگان
چکیده
منابع مشابه
Treatment of systemic hypertension.
Systemic hypertension is a major risk factor for cardiovascular disease and is present in 69% of patients with a first myocardial infarction, in 77% of patients with a first stroke, in 74% of patients with chronic heart failure, and in 60% of patients with peripheral arterial disease. Double-blind, randomized, placebo-controlled trials have found that antihypertensive drug therapy reduces cardi...
متن کاملSystemic and renovascular hypertension.
To ascertain the contribution of systemic hypertension in the progression of renal failure, we have studied the effects of pharmacological treatment of hypertension in rats with the remnant kidney model of renal insufficiency, streptozotocin diabetes, or nephrotoxic serum nephritis. Treatment with the angiotensin converting enzyme (ACE) inhibitor enalapril lowered systemic blood pressure in the...
متن کامل[Systemic hypertension and anesthesia.].
BACKGROUND AND OBJECTIVES Due to the high incidence of systemic hypertension and the lack of consensus on pressure levels to be accepted before inducing anesthesia for elective procedures, literature associated to hypertension and anesthesia was reviewed. Considering that canceling a surgery implies expenses making Medicine increasingly more expensive and that, on the other hand, anesthesia sho...
متن کاملPulmonary hypertension in systemic sclerosis.
A woman born in 1912 (Case 8 in the necropsy series) had an unremarkable family history. In 1940, she first noted blanching and cyanosis of the fingers on exposure to cold. Since 1960, small, hard, subcutaneous nodules developed at different locations on her body. Early in 1968, progressive effort dypsnoea and anginal chest pains started insidiously, and treatment with digitalis, furosemide, an...
متن کاملEchocardiographic Changes in Systemic Hypertension
Backgroud: Older patients with hypertensive blood pressure have a higher risk of cardiovascular complication when compared to younger hypertensives. Echocardiography is the non invasive procedure of choice in the evaluation of the cardiac effects of systemic hypertension. Objective: To study the echocardiographic changes resulting from systemic hypertension in age group between 61-70 years. Met...
متن کاملذخیره در منابع من
با ذخیره ی این منبع در منابع من، دسترسی به آن را برای استفاده های بعدی آسان تر کنید
ژورنال
عنوان ژورنال: Kidney International
سال: 1994
ISSN: 0085-2538
DOI: 10.1038/ki.1994.57